Netherlands vs Pakistan: Previously treated cases tested for RR-/MDR-TB
Netherlands
75.0%
in 2024
Pakistan
75.0%
in 2024
Netherlands rank
123rd
Pakistan rank
123rd
Previously treated cases tested for RR-/MDR-TB over time
- Netherlands
- Pakistan
How they compare
Netherlands currently reports 75.0% against 75.0% in Pakistan, a difference of 0.0%.
The two have swapped places 5 times across 15 shared years of data; in 2008 it was Netherlands ahead.
Netherlands ranks 123rd and Pakistan ranks 123rd of 180 countries.
Across the 3 decades both report, Netherlands averaged higher in 2 and Pakistan in 1.
Head to head by decade
| Decade | Netherlands | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 62.5% | 0.6% | 61.9% | Netherlands |
| 2010s | 66.9% | 49.7% | 17.2% | Netherlands |
| 2020s | 72.2% | 79.8% | 7.5% | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Netherlands or Pakistan?
- Netherlands, at 75.0% against 75.0% in Pakistan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Netherlands and Pakistan?
- 0.0%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Pakistan?
- 15 years are reported by both, from 2008 to 2024.
- How do Netherlands and Pakistan rank globally for previously treated cases tested for rr-/mdr-tb?
- Netherlands ranks 123rd and Pakistan ranks 123rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.